Regeneron Pharmaceuticals, Inc.

BARCLAYS PLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

311,167

Value ($000)

240,180

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	240,180	0.1%	311,167	12/31/2025
2025 Q3	3/31/2026	183,256	0.1%	325,921	9/30/2025
2025 Q2	2/27/2026	253,589	0.1%	483,026	6/30/2025
2025 Q1	3/17/2026	203,814	0.1%	321,357	3/31/2025
2024 Q4	3/19/2026	274,374	0.1%	385,178	12/31/2024
2024 Q3	3/31/2026	433,896	0.2%	412,747	9/30/2024
2024 Q2	3/23/2026	367,981	0.2%	350,115	6/30/2024
2024 Q1	3/24/2026	330,729	0.1%	343,618	3/31/2024
2023 Q4	3/25/2026	261,939	0.1%	298,237	12/31/2023
2023 Q3	3/26/2026	209,748	0.1%	254,870	9/30/2023
2023 Q2	3/30/2026	200,461	0.1%	278,984	6/30/2023
2023 Q1	3/30/2026	144,856	0.2%	176,295	3/31/2023
2022 Q4	3/30/2026	164,625	0.1%	228,174	12/31/2022
2022 Q3	11/3/2022	107,343	0.1%	155,826	9/30/2022
2022 Q2	8/12/2022	71,080	0.1%	120,242	6/30/2022
2022 Q1	5/16/2022	112,300	0.1%	160,790	3/31/2022
2021 Q4	2/14/2022	309,201	0.2%	489,609	12/31/2021
2021 Q3	11/9/2021	191,999	0.1%	317,262	9/30/2021
2021 Q2	8/13/2021	99,308	0.1%	177,798	6/30/2021
2021 Q1	5/13/2021	74,867	0.1%	158,233	3/31/2021
2020 Q4	2/11/2021	83,664	0.1%	173,182	12/31/2020
2020 Q3	11/12/2020	80,422	0.1%	143,668	9/30/2020
2020 Q2	8/12/2020	104,054	0.2%	166,848	6/30/2020
2020 Q1	5/13/2020	80,691	0.1%	165,250	3/31/2020
2019 Q4	2/10/2020	90,993	0.1%	242,340	12/31/2019
2014 Q1	5/15/2014	39,548	0.1%	131,829	3/31/2014
2013 Q4	2/13/2014	35,306	0.1%	128,376	12/31/2013